Li Li investigates drug safety and security work in Beijing

On September 28, Li Li, secretary of the Party Group of the State Food and Drug Administration, investigated the drug safety guarantee work
in Beijing.
He stressed that it is necessary to conscientiously implement General Secretary Xi Jinping's "four strictest" requirements on drug safety, keep in mind that people's health is the "great power of the country", continue to strengthen the dynamic supervision of all aspects of the whole life cycle of drugs with the work standard of "foolproof" and the risk awareness of "nothing to lose", resolutely ensure the stability of the drug safety situation, resolutely guard the people's drug safety, and go all out to create a good drug safety environment
for the victory of the party's 20th Congress.
Xu Jinghe, member of the party group and deputy director of the State Food and Drug Administration, investigated
together.

Li Li and his party came to Beijing Tongrentang Co.
, Ltd.
to visit and investigate the production processes of Chinese medicine honey pills, such as pills, pills, packaging, etc.
, and carefully understand the company's implementation of drug production quality management practices and ensure the quality and safety of drugs
.
Li Li pointed out that drug safety is a basic public safety, which is related to the health of the people and the survival and development of
enterprises.
Pharmaceutical enterprises should firmly establish the concept that quality is life, comprehensively improve the drug quality management system, strictly implement the work responsibilities of the person in charge of the enterprise, the person in charge of production, the person in charge of quality management and the person authorized in quality, establish and improve the drug traceability system, and be responsible for
the safety, effectiveness and quality controllability of the whole life cycle of the drug 。 The regulatory departments should take the special rectification action of drug safety as the main starting point, further strengthen the investigation and rectification of potential safety hazards, not only adhere to the whole life cycle supervision, but also highlight key varieties, key enterprises, key areas, and key links, implement the risk list system, the risk verification system, and the risk sales number system, and strive to achieve the dynamic clearance
of points, lines and surfaces of drug safety hazards.

At Beijing Hotview Biotechnology Co.
, Ltd.
, Li Li and his party carefully understood the production, storage, circulation and use of new coronavirus detection reagents, and inspected
the key links of the quality management system such as assembly, filling, labeling and warehouse 。 Li Li pointed out that the quality and safety of drugs and medical devices needed for epidemic prevention and control are related to the overall situation of epidemic prevention and control, and drug regulatory departments should resolutely shoulder their duties and missions, coordinate the use of supervision and sampling, daily inspection, flight inspection, complaint and reporting, monitoring and evaluation, etc.
, continue to strengthen the supervision of epidemic prevention materials such as new coronavirus detection reagents, severely crack down on violations of laws and regulations, resolutely adhere to the bottom line of quality and safety, consolidate hard-won regulatory results, and provide a strong guarantee
for epidemic prevention and control.

At the China Institute of Food and Drug Control, Li Li and his party visited the front-line drug supervision staff and inspected and supervised the work of
drug inspection and testing, safe production, and biosafety management.
Li Li stressed that it is necessary to follow the principles of science, standardization, and fairness, conscientiously and meticulously do a good job in drug supervision and sampling, vaccine batch issuance, and standard revision and other work, strengthen the use of inspection and testing results, and give play to the role of
regulatory tentacles.
With the sense of responsibility of "not being assured at all times", we should further strengthen the closed-loop management of the whole chain of sample receipt, inspection and sample retention, improve the level of biosecurity management of hazardous chemicals, biological products, bacterial and poison seed banks, and strictly implement measures such as fire prevention and theft prevention to ensure the safety
of the hospital.
It is necessary to conscientiously implement the requirements of the prevention and control of the epidemic in the territory, do a solid job in the investigation and resolution of petitioning and maintaining stability and social contradictions, effectively achieve safety, harmony and stability, and create a good environment
for the victory of the 20th National Congress of the Party.

The director of drug safety of the State Food and Drug Administration, the responsible comrades of the Department of Drug Supervision and the Department of Device Supervision respectively participated in the survey
.